ERBB2 and neoplasm: In order to confirm that UniCAR T cells targeted by a HER2-specific soluble linker can penetrate established tumor xenografts, we performed an in vivo experiment in which mice were xenotransplanted with trastuzumab-resistant MDA-HER2 cells.